118 related articles for article (PubMed ID: 36903490)
21. Involvement of the dopamine D
Zhang K; Lu J; Yao L
J Pharmacol Sci; 2020 Jan; 142(1):26-33. PubMed ID: 31786058
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive effect of N-(3-(phenylselanyl)prop-2-yn-1-yl)benzamide in mice: Involvement of 5-HT
Ledebuhr KNB; Nunes GD; Besckow EM; Giehl MR; Godoi B; Bortolatto CF; Brüning CA
Chem Biol Interact; 2022 May; 359():109918. PubMed ID: 35351428
[TBL] [Abstract][Full Text] [Related]
23. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
[TBL] [Abstract][Full Text] [Related]
24. 3-(4-Chlorophenylselanyl)-1-methyl-1H-indole, a new selenium compound elicits an antinociceptive and anti-inflammatory effect in mice.
Birmann PT; Sousa FSS; de Oliveira DH; Domingues M; Vieira BM; Lenardão EJ; Savegnago L
Eur J Pharmacol; 2018 May; 827():71-79. PubMed ID: 29535001
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory and antinociceptive activities of glucagon-like peptides: evaluation of their actions on serotonergic, nitrergic, and opioidergic systems.
Aykan DA; Kesim M; Ayan B; Kurt A
Psychopharmacology (Berl); 2019 Jun; 236(6):1717-1728. PubMed ID: 30607480
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive effect of butyl (2-phenylethynyl) selenide on formalin test in mice: Evidences for the involvement of serotonergic and adenosinergic systems.
Luchese C; Prigol M; Acker CI; Nogueira CW
Eur J Pharmacol; 2010 Oct; 644(1-3):49-54. PubMed ID: 20621089
[TBL] [Abstract][Full Text] [Related]
27. Depression- and anxiogenic-like behaviors induced by lipopolysaccharide in mice are reversed by a selenium-containing indolyl compound: Behavioral, neurochemical and computational insights involving the serotonergic system.
Casaril AM; Domingues M; de Andrade Lourenço D; Birmann PT; Padilha N; Vieira B; Begnini K; Seixas FK; Collares T; Lenardão EJ; Savegnago L
J Psychiatr Res; 2019 Aug; 115():1-12. PubMed ID: 31082651
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid from Agastache mexicana aerial parts produces antinociceptive activity involving TRPV1 receptors, cGMP and a serotonergic synergism.
Verano J; González-Trujano ME; Déciga-Campos M; Ventura-Martínez R; Pellicer F
Pharmacol Biochem Behav; 2013 Sep; 110():255-64. PubMed ID: 23932918
[TBL] [Abstract][Full Text] [Related]
29. Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates.
Rupniak NM; Boyce S; Tye S; Cook G; Iversen SD
Pharmacol Biochem Behav; 1993 Jan; 44(1):153-6. PubMed ID: 8094250
[TBL] [Abstract][Full Text] [Related]
30. Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment.
Costa CA; Cury TC; Cassettari BO; Takahira RK; Flório JC; Costa M
BMC Complement Altern Med; 2013 Feb; 13():42. PubMed ID: 23432968
[TBL] [Abstract][Full Text] [Related]
31. Sedative and anticonvulsant activities of styrax after oral and intranasal administration in mice.
Guo J; Duan JA; Tang Y; Li Y
Pharm Biol; 2011 Oct; 49(10):1034-8. PubMed ID: 21428734
[TBL] [Abstract][Full Text] [Related]
32. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
33. Chemical composition and evaluation of the anti-inflammatory and antinociceptive activities of Duguetia furfuracea essential oil: Effect on edema, leukocyte recruitment, tumor necrosis factor alpha production, iNOS expression, and adenosinergic and opioidergic systems.
Saldanha AA; Vieira L; Ribeiro RIMA; Thomé RG; Santos HBD; Silva DB; Carollo CA; Oliveira FM; Lopes DO; Siqueira JM; Soares AC
J Ethnopharmacol; 2019 Mar; 231():325-336. PubMed ID: 30445104
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive and anxiolytic-like effects of a
Ortiz-Mendoza N; Zavala-Ocampo LM; Martínez-Gordillo MJ; González-Trujano ME; Peña FAB; Rodríguez IJB; Chávez JAR; Dorazco-González A; Aguirre-Hernández E
Pharm Biol; 2020 Dec; 58(1):620-629. PubMed ID: 32633180
[TBL] [Abstract][Full Text] [Related]
35. Anticonvulsant, anxiolytic and hypnotic effects of aqueous bulb extract of Crinum glaucum A. chev (Amaryllidaceae): role of GABAergic and nitrergic systems.
Ishola IO; Olayemi SO; Idowu AR
Pak J Biol Sci; 2013 Aug; 16(15):701-10. PubMed ID: 24505997
[TBL] [Abstract][Full Text] [Related]
36. The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist.
Montes GC; da Silva BNM; Rezende B; Sudo RT; Ferreira VF; de Carvalho da Silva F; da Cunha Pinto A; da Silva BV; Zapata-Sudo G
Molecules; 2017 May; 22(5):. PubMed ID: 28509855
[TBL] [Abstract][Full Text] [Related]
37. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain.
Duman EN; Kesim M; Kadioglu M; Yaris E; Kalyoncu NI; Erciyes N
J Pharmacol Sci; 2004 Feb; 94(2):161-5. PubMed ID: 14978354
[TBL] [Abstract][Full Text] [Related]
38. Lotus Leaf Alkaloid Extract Displays Sedative-Hypnotic and Anxiolytic Effects through GABAA Receptor.
Yan MZ; Chang Q; Zhong Y; Xiao BX; Feng L; Cao FR; Pan RL; Zhang ZS; Liao YH; Liu XM
J Agric Food Chem; 2015 Oct; 63(42):9277-85. PubMed ID: 26448283
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive and anti-inflammatory effects of Memora nodosa and allantoin in mice.
Florentino IF; Silva DPB; Galdino PM; Lino RC; Martins JLR; Silva DM; de Paula JR; Tresvenzol LMF; Costa EA
J Ethnopharmacol; 2016 Jun; 186():298-304. PubMed ID: 27079223
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system evaluation of an ethanol extract of Bidens odorata Cav (Asteraceae) leaves, and its antinociceptive interaction with paracetamol and naproxen.
Alonso-Castro AJ; Zapata-Morales JR; Solorio-Alvarado C; Hernández-Santiago A; Espinoza-Ramírez LA; Carranza-Álvarez C; Ramadoss V
Inflammopharmacology; 2020 Jun; 28(3):749-757. PubMed ID: 31754938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
